[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ORMP":3,"homepage-market-summary":35,"stock-news-ORMP":177},{"ticker":4,"date":5,"profile":6,"dividend":15,"quote":19},"ORMP","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Oramed Pharmaceuticals Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.","13","New York, NY",false,{"dividend_yield":16,"annual_dividend":17,"frequency":18,"next_ex_date":9},5.7208,0.25,"Irregular",{"close":20,"open":21,"high":22,"low":23,"prev_close":24,"change":25,"percent_change":26,"volume":27,"transactions":28,"vwap":29,"high_52w":30,"low_52w":31,"avg_volume_52w":32,"range_52w_percent":33,"record_count":34},4.37,4.425,4.45,4.35,4.38,-0.01,-0.23,84722.441723,1248,4.394,5.47,2.09,215570.20974192032,67.5,4891,{"status":36,"indices":37,"watchlist":80,"sectors":102,"benchmarks":157},"success",[38,45,52,59,65,72],{"symbol":39,"name":40,"price":41,"change":42,"pct_change":43,"is_up":14,"sparkline":44,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":46,"name":47,"price":48,"change":49,"pct_change":50,"is_up":14,"sparkline":51,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":53,"name":54,"price":55,"change":56,"pct_change":57,"is_up":14,"sparkline":58,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":60,"name":61,"price":62,"change":63,"pct_change":43,"is_up":14,"sparkline":64,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":66,"name":67,"price":68,"change":69,"pct_change":70,"is_up":14,"sparkline":71,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":73,"name":74,"price":75,"change":76,"pct_change":77,"is_up":78,"sparkline":79,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[81,88,95],{"symbol":82,"name":83,"price":84,"change":85,"pct_change":86,"is_up":14,"sparkline":87,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":89,"name":90,"price":91,"change":92,"pct_change":93,"is_up":78,"sparkline":94,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":96,"name":97,"price":98,"change":99,"pct_change":100,"is_up":14,"sparkline":101,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[103,108,113,118,123,128,133,138,143,147,152],{"name":104,"etf":105,"change":106,"price":107,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":109,"etf":110,"change":111,"price":112,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":114,"etf":115,"change":116,"price":117,"is_up":78},"Healthcare","XLV",1.03,168.81,{"name":119,"etf":120,"change":121,"price":122,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":124,"etf":125,"change":126,"price":127,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":129,"etf":130,"change":131,"price":132,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":134,"etf":135,"change":136,"price":137,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":139,"etf":140,"change":141,"price":142,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":144,"etf":145,"change":70,"price":146,"is_up":14},"Real Estate","XLRE",40.57,{"name":148,"etf":149,"change":150,"price":151,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":153,"etf":154,"change":155,"price":156,"is_up":14},"Comm Services","XLC",-0.35,111.26,[158,163,168,173],{"ticker":159,"name":160,"price":161,"change":162,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":164,"name":165,"price":166,"change":167,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":169,"name":170,"price":171,"change":172,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":174,"name":175,"price":176,"change":70,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":178,"articles":179},9,[180,186,191,197,202,208,213,218,223],{"title":181,"link":182,"pubDate":183,"description":184,"source":185},"A planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQSy02S1gwcnlOQVVPdEJsZ1R5aUVDSjdYYkdYRFlNME5WQkI3WHhrak55Uy1DX0RQRkhDOEl6TlhzWG5Ua1VOOXZ1V3dvV1lQenJoYmt5aXFUbUZrTlA2RFBqR1lxcjVWVFYwakR3V2RENHJlZ2JiM3lwN2lrY1pqemlSNTh1OWRfa3dXTV95SHdTNUFmcWpxX05Qa0ZJbHA2V3pjOUpMVGdQeThxbExxYk9WR3c3V2xNa042Yw?oc=5","Fri, 02 Oct 2026 21:19:52 GMT","A planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. Stock Titan","Stock Titan",{"title":187,"link":188,"pubDate":189,"description":190,"source":185},"An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxOX1hsODY2US1VSWgtRWFSRmNnOHFPWUpnV3JaSS1wT2h2RDhVZlY4MkRFeGZiR3JNSmNWX0hxRm92RUNkTTdhTEszQVRXRWtEVVZzZV9wZl9SQ3pTcTFjazllOWF5R2VCM2RaS0hNaHQtbUFST0d6VlcwSTRPN1NKMXRLU3lhdGlsNGpTNE5qcW5nNU1vRUZramVyZG05V3JMRWl2LUF3?oc=5","Thu, 01 Oct 2026 11:44:11 GMT","An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. Stock Titan",{"title":192,"link":193,"pubDate":194,"description":195,"source":196},"Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxNWTV6WEwyMldEOEFMUFFJdFR2UmR3MzQxUkRmaHgzNkhKWGUzUkU3U2szSjFoMXAtUUlkdE8tdFZRWXNLa2ZPZ2tqWXBmY2lNcmlJMFZDVmVlN0F4VnVhOVZDempULXFCbWZ1VG1TVGttZEFWZ3I1QUc5TEhnUktvb1NvQjloczhMa2xCX1hOemVUY0NFZk84UDdMVXgtOXE3TGhlY3B3ZmRsQ2VMWmRLRFVCWXlqNUlYZVo2WlRTU3ZpOEVx?oc=5","Fri, 02 Oct 2026 22:20:13 GMT","Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock Investing.com","Investing.com",{"title":198,"link":199,"pubDate":200,"description":201,"source":185},"Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNeGluR0pfcHhOQWRKYzR0dG9TQnZrdlYzc05fMDUzS3dicHZSWVg4bmZTRVVTaXBQclhUZDhSclEtSWRkU2otR2JmZHZZa2lxWmt4S05nZ2lwYXJmemhwMDg3QTF4a2RuWUF6dkxfSnFkQ1VMWWYwLUpwYmo2eXJHbXlXZ1dkWVJZbzZ6VVpVT1poWmpsTUJXS2UwWkU4UHE2ZlZSUmdHLUZKNmo3RFU2WWVENG4yYmJ2S0tybA?oc=5","Fri, 02 Oct 2026 21:19:43 GMT","Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. Stock Titan",{"title":203,"link":204,"pubDate":205,"description":206,"source":207},"Oramed Pharmaceuticals stock fell 3.74 percent as targets rose - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxONUtjazJHa1hISjUwS0pncEVfclkzNUFtTkJyN21NbC0zRUM0ZDNYcG50dk96T0I0WFNqNHNlTzczMldmMHdxVmpnRTh2Rk5oVDN4RHUwYmIySEI1OU03RTNFR1Y3VXJiRlR6dUNFTzRLdDZ4WVY2OFF6Q2psQ0IyTl9uRDNqRFhJX3lxcko3WGdBd0pSbTBwS2NPWmpZMDZ5UG1oNnZyQlF6V3haWWpUWk9ndTZ3Nlpyd1pOLWV3?oc=5","Wed, 07 Oct 2026 05:27:16 GMT","Oramed Pharmaceuticals stock fell 3.74 percent as targets rose AD HOC NEWS","AD HOC NEWS",{"title":209,"link":210,"pubDate":211,"description":212,"source":185},"40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNUnQ0RXIzUGI2MndGZUpMUEpkbHUtVzRmb1lqN3FJdWZxLUUzTWR1TVZkVmRyS0lidVhXdFR6bkN6SzJGM1F3aWRycjBlZzlZNWZmaWx2T19MOWVEdDZ3djc4ZDVFY3A1MTRGMXBhN09CRWlhekxtLXlCNzkxRFByZWlWc3JfQUlwS3VNNGowT2d2OE9YT2tOV29QWWsxclVRbXpYTG5NNlVmYWd0WFJYb1BMZng0TnBMZmJycg?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. Stock Titan",{"title":214,"link":215,"pubDate":216,"description":217,"source":207},"Oramed officer proposes USD 140,100 sale of Oramed Pharmaceuticals stock - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxPdUxBV1BabkYtOWhVYzhEYlZxcmxsR1l5dW8yeXNYQ0x5M29Cd0M4TGZEdXN2aEtwWGRrS09SY1ZGM0tmZkc1SzNqNnVqanVyZ1NzbHhfLTZGM3Z3azF6emhMSnVIMHJzN0tjVWtQdjJRX0JGVVdRLWdQd0NnUzVfUlFWa3JFLTNMdng4V3hQb2hvclFVTUlvN1VtcDZEVVRuM0hMcGFnd0p0enA1NWxnUERSdjl5eFdnQUxYRFBqTHNxVGM0R0Z5NzJMcw?oc=5","Fri, 02 Oct 2026 10:07:42 GMT","Oramed officer proposes USD 140,100 sale of Oramed Pharmaceuticals stock AD HOC NEWS",{"title":219,"link":220,"pubDate":221,"description":222,"source":185},"A trading plan underpins an officer's proposed $140K share sale at Oramed (ORMP). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxONVlYbVBDQmZMbENvXzRoYnNENEdxc1V2SHZLWHJ5dWlZOUlwMzdETmNxblhjdmxXcy13QllDQzJwRHJaMnZQb0Zpa3pPZnM0OURmT2kzcFZRNTI2OEJ5MmZEUGhhTl9CV2R1ZjBZMU82cERRckFXTmlUblJKYkxiNHFPeDF1NEhjaUI5VHF6djJIREN2eGhZb3FYeVBtbnEzbGxhWGhn?oc=5","Thu, 01 Oct 2026 11:39:25 GMT","A trading plan underpins an officer's proposed $140K share sale at Oramed (ORMP). Stock Titan",{"title":224,"link":225,"pubDate":226,"description":227,"source":185},"Six option grants were canceled in exchange for a fully vested stock award to Oramed (ORMP) CEO Nadav Kidron. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPWjJBYk9Pa0tWeVRUWWNidmNjdll3U21hM3gzVUdXTmFJME53cWJBbFB1MTNadG84UG5mMHZ1N2JXaVNQNVRDZ0NpWUpBNVRoc1NObVpLWjlfeEhiOU5sam52V1NLYnh1bVUzX3Z0cUZnS1BpZUgtWXNKYnl1Yi1ERDZkTDhyN1FFTU5PaTl0MzNWRHc0SnFWcHcwc19YYjBHMFFPZ3QyNndtdDNmTndfY2h3SndBY0hHanpQSQ?oc=5","Fri, 25 Sep 2026 20:43:49 GMT","Six option grants were canceled in exchange for a fully vested stock award to Oramed (ORMP) CEO Nadav Kidron. Stock Titan"]